ArticleEuropean radiology2017

Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.

Nirmitha I Herath et al.PubMed ↗Publisher ↗

No numbers read from the abstract.